Form 4: Ashland SVP Assis Reports Stock Transactions

Ashland's SVP and GM of Life Sciences, Alessandra Faccin Assis, reported the acquisition of common stock and the disposition of shares for tax purposes related to Restricted Stock Units.

Summary

• Alessandra Faccin Assis, SVP and GM of Life Sciences at Ashland Inc. (ASH), reported transactions involving the company's common stock.
• On November 13, 2025, Assis acquired 1,340 shares of common stock at a price of $53.1 per share.
• Concurrently, 570 shares of common stock were disposed of at $53.1 per share to cover tax liabilities related to the vesting of Restricted Stock Units (RSUs).
• Following these transactions, Assis directly beneficially owns 5,716 shares of common stock.
• Assis also acquired 1,340 Restricted Stock Units (RSUs) on November 13, 2025, which represent a right to receive one share of Ashland Common Stock per unit.
• The RSUs vest in three equal installments, beginning one year from the grant date, contingent on continuous employment with Ashland.
• The balance of derivative securities beneficially owned, including additional RSUs acquired in lieu of cash dividends, is 2,680 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation and tax obligations, which are neutral in sentiment. There are no significant positive or negative implications for the company's financial health or strategic direction.

Positives

• The reporting person acquired 1,340 shares of common stock, indicating continued ownership and alignment with shareholder interests.
• The Restricted Stock Unit plan, under which these transactions occurred, was approved by shareholders, reflecting good corporate governance.

Negatives

• 570 shares were disposed of to satisfy tax withholding obligations, which is a routine event and not indicative of a negative outlook.

Risks

• The vesting of Restricted Stock Units is contingent upon the reporting person's continuous employment with the Issuer, posing a personal risk to the reporting person's full realization of the award.

Future Outlook

The Restricted Stock Units acquired are scheduled to vest in three equal installments, with the first vesting occurring approximately one year from the grant date of November 13, 2025, provided the reporting person maintains continuous employment.

Industry Context

This filing represents a routine insider transaction, common across all industries, where executives report changes in their beneficial ownership of company securities, often related to compensation plans like Restricted Stock Units.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine insider transaction related to executive compensation. It demonstrates continued executive ownership.
• Employees: The vesting condition of continuous employment highlights the retention aspect of executive compensation plans.

Next Steps

• First installment of Restricted Stock Units will vest approximately one year from November 13, 2025.
• Subsequent installments of Restricted Stock Units will vest in equal parts thereafter, contingent on continuous employment.

Key Dates

Keywords

Ashland Inc., ASH, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation, Stock Acquisition, Tax Withholding, Corporate Governance